The process for continuous improvement of the TNM classification
- PMID: 14692017
- DOI: 10.1002/cncr.11898
The process for continuous improvement of the TNM classification
Abstract
The TNM classification is a worldwide benchmark for reporting the extent of malignant disease and is a major prognostic factor in predicting the outcome of patients with cancer. The objectives for cancer staging were defined by the International Union Against Cancer (UICC) TNM Committee almost 50 years ago and are still broadly applicable today. To keep pace with the modern demands of evidence-based practice, the UICC introduced a structured process for introducing changes to the TNM classification. The elements of the TNM process were determined to include the development of unambiguous criteria for the information and documentation required to consider changes in the classification, establishment of a well-defined process for the annual review of relevant literature, formation of site-specific expert panels, and the participation of experts from all over the world in the TNM review process. Communication between the oncology community and those involved in the TNM classification was established as being essential to the success of the process. The process, which was introduced in 2002, will be tested over the next 3-4 years and evaluated. In addition to the formal process, individual initiative, involvement by the national staging committees, and group consensus are required. Furthermore, increased involvement by the experts should improve the understanding and dissemination of the TNM classification.
Similar articles
-
Evidence-based medicine: the time has come to set standards for staging.J Pathol. 2010 Aug;221(4):357-60. doi: 10.1002/path.2720. J Pathol. 2010. PMID: 20593493
-
[1992 tumor classification/developments].Langenbecks Arch Chir Suppl Kongressbd. 1992:40-5. Langenbecks Arch Chir Suppl Kongressbd. 1992. PMID: 1493294 German.
-
TNM: evolution and relation to other prognostic factors.Semin Surg Oncol. 2003;21(1):3-7. doi: 10.1002/ssu.10014. Semin Surg Oncol. 2003. PMID: 12923909
-
History and international developments in cancer staging.Cancer Prev Control. 1998 Dec;2(6):262-8. Cancer Prev Control. 1998. PMID: 10470455 Review.
-
Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why?Virchows Arch. 2018 Apr;472(4):519-531. doi: 10.1007/s00428-017-2276-y. Epub 2017 Dec 5. Virchows Arch. 2018. PMID: 29209757 Review.
Cited by
-
Circulating tumor cells in genitourinary tumors.Ther Adv Urol. 2017 Nov 22;10(2):65-77. doi: 10.1177/1756287217742564. eCollection 2018 Feb. Ther Adv Urol. 2017. PMID: 29434674 Free PMC article. Review.
-
The evolving TNM cancer staging system: an essential component of cancer care.CMAJ. 2006 Jan 17;174(2):155-6. doi: 10.1503/cmaj.045113. CMAJ. 2006. PMID: 16415456 Free PMC article. No abstract available.
-
Do we need to redefine a cancer metastasis and staging definitions?Breast Dis. 2006-2007;26:3-12. doi: 10.3233/bd-2007-26102. Breast Dis. 2006. PMID: 17473362 Free PMC article. Review.
-
Biomarkers in precision therapy in colorectal cancer.Gastroenterol Rep (Oxf). 2013 Nov;1(3):166-83. doi: 10.1093/gastro/got022. Epub 2013 Aug 23. Gastroenterol Rep (Oxf). 2013. PMID: 24759962 Free PMC article.
-
Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.Clin Exp Med. 2024 Feb 28;24(1):44. doi: 10.1007/s10238-024-01296-1. Clin Exp Med. 2024. PMID: 38413421 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources